Baird Medical Investment Holdings Limited(BDMD) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.55 | Insider Own | 61.4% | Shs Outstand | 42.2M | Perf Week | -3.57% |
| Market Cap | 0.05B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 16.3M | Perf Month | -7.69% |
| Enterprise Value | 0.06B | PEG | - | EPS next Q | 0.08 | Inst Own | 0.75% | Short Float | 0.15% | Perf Quarter | -14.29% |
| Income | -0.02B | P/S | 1.86 | EPS this Y | - | Inst Trans | -3.38% | Short Ratio | 0.34 | Perf Half Y | -58.14% |
| Sales | 0.02B | P/B | 1.27 | EPS next 5Y | - | ROA | -21.18% | Short Interest | 0.02M | Perf YTD | -20.59% |
| Book/sh | 0.85 | P/C | 157.18 | EPS past 3/5Y | - -152.36% | ROE | -45.4% | 52W High | -70.81% ($3.70) | Perf Year | -56.63% |
| Cash/sh | 0.01 | P/FCF | - | Sales past 3/5Y | - | ROIC | -45.93% | 52W Low | 42.67% ($0.76) | Perf 3Y | -89.78% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -1.02% | Gross Margin | 85.63% | Volatility(W/M) | 8.69% 9.55% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 2.42 | Sales Y/Y TTM | - | Oper. Margin | -58.52% | ATR (14) | 0.1 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.26 | EPS Q/Q | 36.52% | Profit Margin | -65.2% | RSI (14) | 44.33 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.29 | Sales Q/Q | - | SMA20 | -4.85% ($1.14) | Beta | -1.16 | Target Price | $4 |
| Payout | - | Debt/Eq | 0.41 | Earnings | 2026/9/3 | SMA50 | -3.38% ($1.12) | Rel Volume | 0.27 | Prev Close | $1.12 |
| Employees | 146 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -26.26% ($1.46) | Avg Volume(3M) | 0.07M | Price | $1.08 |
| IPO | 2021/12/16 | Option/Short | No/Yes | Trades | 112 | Volume | 19,768 | Change | -3.57% |
Company
BDMD is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A global medical device company specializing in the treatment of thyroid nodules and breast tumors through microwave ablation (MWA) technology. Leveraging its non-invasive surgical solutions, the company is expanding its market reach beyond China to the Americas and across Asia.
Over the past 1 year, on the lower side
71% below its 1-year high.
BDMD has weak earning power
Losses or thin margins. Early-stage growth or weakening competitiveness
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Results came in about as expected
Generally in line with estimates
Tap to view numbers
Opinions on the outlook are split
Positive and negative signals are mixed
Tap to view numbers
Holding long would have lost money
Would have changed by -89.8% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 0.8%.
Tap to view numbers
It ranks #4 in the industry
Based on market cap of $46M.
BDMD $46M PER -
ABT $179B PER 33.4
MDT $117B PER 22.6
SYK $104B PER 28.0
FAQ
What kind of company is BDMD?
BDMD belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of BDMD?
The market cap of BDMD is approximately $46M, ranking 4,977 within its sector.
What is the 52-week high and low for BDMD?
BDMD has recorded a 52-week high of $3.70 and a low of $0.76.
